Abstract
The treatment of cancer has undergone many advances in recent years, leading to significant increases in patient survival. Improvements have come not only in the therapies themselves, but also in our ability to sustain critically ill patients. This, in turn, has allowed more intensive cytotoxic chemotherapies and an increased application of bone marrow transplantation for a broader range of neoplasms. More aggressive chemotherapy regimens have led to more profound immunosuppression and increased risk of infection. Longer survival in more critically ill patients, as well as the relative success of antibacterial therapies, have contributed to a dramatic increase in the incidence of invasive fungal disease among oncology patients. Additional risk factors for fungal infection, common in cancer patients, include the interruption of natural protective barriers by indwelling intravascular catheters, extensive surgical procedures, and chemotherapy-induced disruption of mucosal integrity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anaissie E. Opportunistic mycoses in the immunocompromised host: Experience at a cancer center and review. Clin Infect Dis 1992;14(Suppl. 1):S43–S53.
Wingard JR. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995;20:115–125.
Swerdloff JN, Filler SG, Edwards JE. Severe candidal infections in neutropenic patients. Clin Infect Dis 1993;17(Suppl. 2):S457–S467.
Slavin MA, Osborne B, Adams R, Levenstein MJ, Schoch HG, Feldman AR, Meyers JD, Bowden RA. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation — A prospective, randomized, double-blind study. J Infect Dis 1995;171:1545–1552.
Wey SB, Mori M, Pfaller MA, Soolson RF, Wenzel RP. Hospital-acquired candidemia: The attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642–2645.
Merz WG. Candida lusitaniae: Frequency of recovery, colonization, infection, and amphotericin B resistance. J Clin Microbiol 1984;20:1194–1195.
Voss A, Pfaller MA, Hollis RJ, Rhine-Chalberg J, Doebbeling BN. Investigation of Candida albicans transmission in a surgical intensive care unit cluster with genomic DNA typing methods (abstract no. 1638). In: Program and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington DC: American Society for Microbiology, 1993.
Weems JJ. Candida parapsilosis: Epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis 1992;14:756–766.
Beck-Sague CM, Jarvis WR, Banerjee SN, Culver DH, Gaynes RP. Nosocomial fungal infections in U.S. hospitals, 1980-1990 (abstract no. 1129). In: Program and abstracts of the 30th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC-American Society for Microbiology, 1990.
Komshian SV, Uwaydah, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient. Rev Infect Dis 1989;11:379–390.
Merz WG, Karp JE, Schron D, Saral R. Increased incidence of fungemia cuased by Candida krusei. J Clin Microbiol 1986;24:581–584.
Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991;325:1274–1277.
Bignardi GE, Savage MA, Coker R, Davis SG. Fluconazole and Candida krusei infections [letter]. J Hosp Infect 1991;18:326–327.
Mcllroy MA. Failure of fluconazole to suppress fungemia in a patient with fever, neutropenia and typhlitis [letter]. J Infect Dis 1991;163:420–421.
Person DA, Laughlin M, Tanner D, Perfect J, Gockerman JP, Hathorn JW. Fluconazole and Candida knisei fungemia [letter], N Engl J Med 1991;325:1315.
Diamond RD, Lyman CA, Wysong DR. Disparate effects of interferon and tumor necrosis factor in early neutrophil respiratory burst and fungicidal responses to Candida albicans hyphae in vitro. J Clin Invest 1991;87:711–720.
Lyman CA, Simons ER, Melnick DA, et al. Induction of signal transduction in human neutrophils by Candida albicans hyphae: The role of pertussis toxin-sensitive guanosine triphosphate-binding proteins. J Infect Dis 1988;158:1056–1064.
Fleischmann J, Lehrer RI. Phagocytic mechanism in host response. In: Howard DH, ed. Fungi Pathogenic for Humans and Animals, Part B2. New York: Marcel Dekker, 1985, pp. 123–149.
Brown AE. Overview of fungal infections in cancer patients. Semin Oncol 1990;17(Suppl. 6):2–5.
Odds FC, Schmid J, Soll DR. Epidemiology of Candida infections in AIDS. In: Vanden Bossche H, MacKenzie DWR, Cauwenbergh G, Van Cutsem J, Drouhet E, Dupont B, eds. Mycoses in AIDS patients. New York: Plenum Press, 1990, pp. 67–74.
Lecciones JA, Lee JW, Navarro EE, et al. Vascular catheter-associated fungemia in patients with cancer: Analysis of 155 episodes. Clin Infect Dis 1992;14:875–883.
Isenberg HD, Tucci V, Cintron F, Singer C, Weinstein GS, Tyras DH. Single-source outbreak of Candida tropicalis complicating coronary bypass surgery. J Clin Microbiol 1989;27:2426–2428.
Martino P, Girmenia C, Venditti M, et al. Candida colonization and systemic infection in neutropenic patients: A retrospective study. Cancer 1989;64:2030–2034.
Cole GT, Halawa AA, Anaissie EJ. The role of the gastrointestinal tract in hematogenous candidiasis: From the laboratory to the bedside. Clin Infect Dis 1996;22(Suppl. 2):s73–s88.
Krause W, Matheis H, Wulf K. Fungemia and funguria after oral administration of Candida albicans. Lancet 1969;l:598–599.
Stone HH, Kolb LD, Currie CA, et al. Candida sepsis: Pathogenesis and principles of treatment. Ann Surg, 1974:697–711.
Wade JC. Epidemiology of Candida infection. In: Bodey GP, ed. Candidiasis: Pathogenesis, Diagnosis, and Treatment, 2nd ed. New York: Raven Press, 1993, p. 85.
McDonald G, Sharma P, Hackman R, Meyers J, Thomas ED. Infectious esophagitis in immunocompromised patients after marrow transplantation. Gastroenterology 1985, 88:1111–1117.
Pfaller MA. Epidemiology and control of fungal infections. Clin Infect Dis 1994;19(Suppl. 1):S8–S13.
Edwards JE. Candida species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 4th ed. New York: Churchill Livingstone, 1995, pp. 2289–2305.
Walsh, TJ, Lee JW, Roilides E, Pizzo PA. Recent progress and current problems in management of invasive fungal infections in patients with neoplastic deseases. Curr Opin Oncol 1992;4:647–655.
Bodey GP. Disseminated candidiases in neutropenic patients. Int J Infect Dis 1997;l(Suppl. 1):S2–S6.
Flynn PM, Shenep JL, Crawford R, Hughes WT. Use of abdominal computed tomography for identifying disseminated fungal infection in pediatric cancer patients. Clin Infect Dis 1995;20:964–970.
Meunier F, Aoun M, Bitar N. Candidemia in immunocompromised patients. Clin Infect Dis 1992;14(Suppl. l):S120–S125.
Lecciones J, Witebsky F, Marshall D, Gress J, Pizzo P, Walsh TJ. Catheter-associated fungemia in cancer patients: Characteristics and clinical outcome (abstract no. 68). In: Program and Abstracts of the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology, 1989, p. 112.
Edwards JE. Invasive Candida infection. N Engl J Med 1991;324:1060–1062.
Young RC, Bennett JE, Geelhoed GW, et al. Fungemia with compromised host resistance. A study of 70 cases. Ann Intern Med 1974;80:605–612.
Polak A. 5-Fluorocytosine and combinations. Ann Biol Clin (Paris) 1987;45:669–672.
Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994;331:1325–1330.
Stevens DA. Overview of amphotericin B colloidal dispersion (amphocil). J Infect 1994;28(Suppl. 1):S45–S49.
Eppes SC, Troutman JL, Gutman LT. Outcome of treatment of candidemia in children whose central catheters were removed or retained. Pediatr Infect Dis J 1989;8:99–104.
Dato VM, DAjani AS. Candidemia in children with central venous catheters: Role of catheter removal and amphotericin B therapy. Pediatr Infect Dis J 1990;9:309–314.
Bennett JE. Aspergillus species. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 4th ed. New York: Churchill Livingstone, 1995, pp. 2306–2310.
Talbot GH, Huang A, Provencher M. Invasive Aspergillus rhinosinusitis in patients with acute leukemia. Rev Infect Dis 1991;13:219–232.
Peterson DE, Schimpff SC. Aspergillus sinusitis in neutropenic patients with cancer: A review. Biomed Pharmacother 1989;43:307–312.
Young RC, Bennett JE, Vogel CL, et al. Aspergillosis. The spectrum of the disease in 98 patients. Medicine 1970;49:147–173.
Meyer RD, Young LS, Armstrong D, et ai. Aspergillosis complicating neoplastic disease. Am J Med 1973;54:6.
Pagano L, Ricci P, Nosari A, Tonso A, Buelli M, Montillo M, Cudillo L, et al. Fatal haemoptysis in pulmonary filamentous mycosis: An underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature. Br J Haematol 1995;89:500–505.
Wallace TM Jr., Sais GJ, Frank I, Gefter WB, Aronchick JM, Wallace TM. Pulmonary aspergillosis in patients with AIDS. Chest 1994;105:37–44.
Young RC, Jennings A, Bennett Je. Species identification of invasive aspergillosis in man. Am J Clin Pathol 1972;58:554–557.
Green WR, Font RI, Zimmerman LE. Aspergillosis of the orbit. Report of ten cases and review of the literature. Arch Ophthalmol 1969:82:302–313.
Allo MD, Miller J, Townsend T, Tan C. Primary cutaneous aspergillosis associated with Hickman intravenous catheters. N Engl J Med1987;317:1105–1108.
Kusne S, Torre-Cisneros J, Manez R, et al. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus cultures after liver transplantation. J Infect Dis 1992;166:1379–1383.
Boon AP, O’Brien D, Adams DH. 10 year review of invasive aspergillosis detected at necropsy. J Clin Pathol 1991;44:452–454.
von Eiff M, Roos N, Schulten R, Hesse M, Zuhlsdorf M, van de Loo J. Pulmonary aspergillosis: Early diagnosis improves survival. Respiration 1995;62:341–347.
Hruban RH, Meziane MA, Zerhouni EA, Wheeler PS, Dumler JS, Hutchins GM. Radiologie-pathologic correlation of the CT halo sign in invasive pulmonary aspergillosis. J Comput Assist Tomogr 1987;11:534–536.
Faggian G, Livi U, Bortolotti U, et al. Intraconazole therapy for acute invasive pulmonary aspergillosis in heart transplantation. Transplant Proc1989;21:2506–2507.
Denning DW, Tucker RM, Hanson LH, et al. Treatment of invasive aspergillosis with itraconazole. Am J Med 1989;86:791–800.
Berthier M, Palmieri O, Lylyk P, et al. Rhino-orbital phycomycosis complicated by cerebral abscess. Neuroradiology 1982;22:221–224.
Meyers BR, Wormser G, Hirschman SZ, et al. Rhinocerebral mucormycosis. Premortem diagnosis and therapy. Arch Intern Med 1979;139:557–560.
Maniglia AJ, Mintz DH, Novak S. Cephalic phycomycosis: A report of eight cases. Laryngoscope 1982;92:755–760.
Abedi E, Sismanis A, Choi K, et al. Twenty five years’ experience treating cerebro-rhino-orbital mucormycosis. Laryngoscope 1984;94:1060–1062.
Lehrer RI, Howard DH, Sypherd PS, et al. Mucormycosis. Ann Intern Med 1980;93:93–108.
Kolbeck PC, Makhoul RG, Bollinger RR, et al. Widely disseminated Cunninghamella mucormycosis in an adult renal transplant patient: A case report and review of the literature. Am J Clin Pathol 1985;83:747–753.
Perfect JR, Schell WA. The new fungal opportunists are coming. Clin Infect Dis 1996;22(Suppl. 2):S112–S118.
D’Antonio D, Mazzoni A, Iacone A, Violante B, Capuani MA, Schioppa F, Romano F. Emergence of fluconazole-resistant strains of Blastoschizomyces capitatus causing nosocomial infections in cancer patients. J Clin Microbiol 1996;34:753–755.
Strausbaugh LJ, Sewell DL, Ward TT, Pfaller MA, Heitzman T, Tjoelker R. High frequency of yeast carriage on hands of hospital personnel. J Clin Microbiol 1994;32:2299–2300.
Vartivarian SE, Anaissie EJ, Bidey GP. Emerging fungal pathogens in immunocopromised patients: Classification, diagnosis, and management. Clin Infect Dis 1993;17(Suppl. 2):S487–S491.
Walsh TJ, Melcher GP, Rinaldi MG, et al. Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. J Clin Microbiol 1990;28:1616–1622.
Hoy J, Hsu K-C, Rolston K, Hopfer RL, Luna M, Bodey GP. Trichosporon beigelii infection: A review. Rev Infect Dis 1986:8:959–967.
Martino P, Venditti M, Micozzi A, Morace G, Polonelli L, Mantovani MP, Petti MC, Burgio VL, Santini C, Serra P, Mandelli F. Blastoschizomyces capitatus: An emerging cause of invasive fungal disease in leukemia patients. Rev Infect Dis 1990;12:570–582.
McManus EJ, Bozdech MJ, Jones JM. Role of the latex agglutination test for cryptococcal antigen in diagnosing disseminated infections with Trichosporon beigelii. J Infect Dis 1985;1167–1169.
Hazen KC. New and emerging yeast pathogens. Clin Microbiol Rev 1995;8:462–478.
Kiehn TE, Gorey E, Brown AE, Edwards FF, Armstrong D. Sepsis due to Rhodotorula related to use of indwelling central venous catheters. Clin Infect Dis 1992;14:841–846.
Martino P, Gastaldi R, Raccah R, Girmenia C. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect 1994;28(Suppl. 1):S7–S15.
Morrison VA, Haake RJ, Weisdorf D J. Non-Candida fungal infections after bone marrow transplantation: Risk factors and outcome. Am J Med1994;96:497–503.
Merz WG, Karp JE, Hoagland M, Jett-Gogeen M, Junkins JM, Hood AF. Diagnosis and successful treatment of fusariosis in the compromised host. J Infect Dis1988;158:1046–1055.
Anaissie E, Kantarjian H, Ro J, et al. The emerging role of Fusarium infections in patients with cancer. Medicine (Baltimore) 1988;67:77–83.
Fotergill AW. Identification of dematiaceous fungi and their role in human disease. Clin Infect Dis 1996;22(Suppl. 2):S179–S184.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Kluwer Academic Publishers, Boston
About this chapter
Cite this chapter
Sanchez, J., Noskin, G.A. (1998). Recent advances in the management of fungal infections. In: Noskin, G.A. (eds) Management of Infectious Complications in Cancer Patients. Cancer Treatment and Research. Springer, Boston, MA. https://doi.org/10.1007/978-0-585-38152-7_6
Download citation
DOI: https://doi.org/10.1007/978-0-585-38152-7_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-7923-8150-1
Online ISBN: 978-0-585-38152-7
eBook Packages: Springer Book Archive